Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.30 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6175645 | 0.72 | HSD11B1 (0.38) | SMN1; SMN2CYP3A4HSD11B1HSD11B2LMNA | |
| Hydrochloric Acid SCHEMBL4611963 | 0.71 | HSD11B1 (0.37) | SMN1; SMN2CYP3A4HSD11B1HSD11B2LMNA | |
| SCHEMBL4941740 | 0.68 | HSD11B1 (0.35) | SMN1; SMN2CYP3A4HSD11B1HSD11B2LMNA | |
| Formic Acid SCHEMBL4941735 | 0.68 | HSD11B1 (0.35) | SMN1; SMN2CYP3A4HSD11B1HSD11B2KDM4E | |
| SCHEMBL27485221 | 0.66 | CYP3A4 (0.33) | SMN1; SMN2CYP3A4 | |
| SCHEMBL15942311 | 0.62 | HPGD (0.34) | GAAALDH1A1 | |
| SCHEMBL232028 | 0.61 | NPSR1 (0.39) | CYP3A4HSD11B1HSD11B2GAAALDH1A1 | |
| SCHEMBL28053497 | 0.61 | HSD11B1 (0.40) | SMN1; SMN2HSD11B1HSD11B2LMNAGAA | |
| SCHEMBL14597531 | 0.60 | ALDH1A1 (0.37) | HSD11B1HSD11B2GAAALDH1A1TP53 | |
| SCHEMBL28481309 | 0.60 | ALDH1A1 (0.37) | HSD11B1HSD11B2GAAALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | COLABS INT'L CORP. (US) | 2024-03-28 | — | — | US | claimed |
| US-20170216164-A1 | Compositions Containing a Flexible Derived Capsule with An Active Agent | CoLabs International Corporation (US) | 2017-08-03 | — | — | US | claimed |
| US-20240415074-A1 | REPELLENT DELIVERY DEVICE WITH GLYCERIN SOAP BODY AND RELATED METHODS | RADICAL AG TECH, INC. | 2024-12-19 | — | — | US | disclosed |
| US-12114610-B2 | Repellent delivery device with glycerin soap body and related methods | RADICAL AG TECH, INC. (US) | 2024-10-15 | — | — | US | disclosed |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | COLABS INT'L CORP. (US) | 2024-03-28 | — | — | US | disclosed |
| US-11839674-B2 | Compositions comprising silicon dioxide-based particles including one or more agents | CoLabs International Corporation (US) | 2023-12-12 | — | — | US | disclosed |
| US-11707421-B2 | Compositions containing a flexible derived capsule with an active agent | COLABS INT'L CORP. (US) | 2023-07-25 | — | — | US | disclosed |
| US-20230113098-A1 | Compositions Containing a Capsule with an Agent | COLABS INT'L CORP. (US) | 2023-04-13 | — | — | US | disclosed |
| US-11491088-B2 | Compositions containing a capsule with a moisturizing agent | CoLabs International Corporation (US) | 2022-11-08 | — | — | US | disclosed |
| US-20210176924-A1 | REPELLENT DELIVERY DEVICE WITH GLYCERIN SOAP BODY AND RELATED METHODS | RADICAL AG TECH, INC. | 2021-06-17 | — | — | US | disclosed |
| US-10322301-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CoLabs International Corporation (US) | 2019-06-18 | — | — | US | disclosed |
| US-20170216164-A1 | Compositions Containing a Flexible Derived Capsule with An Active Agent | CoLabs International Corporation (US) | 2017-08-03 | — | — | US | disclosed |
| US-20170216165-A1 | Compositions Containing a Capsule with a Moisturizing Agent | CoLabs International Corporation (US) | 2017-08-03 | — | — | US | disclosed |
| US-20170157021-A1 | Compositions Containing a Cellulose Derived Capsule with a Sunscreen Active Agent | CoLabs International Corporation (US) | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11707421-B2 | Compositions containing a flexible derived capsule with an active agent | CUTA, LIPE, LIPA | SMN1; SMN2 3151/4885CYP3A4 3480/4885HSD11B1 3460/4885 |
| US-20170216164-A1 | Compositions Containing a Flexible Derived Capsule with An Active Agent | CUTA, LIPE, LIPA | SMN1; SMN2 3151/4885CYP3A4 3480/4885HSD11B1 3460/4885 |
| US-20170157021-A1 | Compositions Containing a Cellulose Derived Capsule with a Sunscreen Active Agent | CUTA, ACMSD, TYR | SMN1; SMN2 3220/4885CYP3A4 2323/4885HSD11B1 1697/4885 |
| US-20230113098-A1 | Compositions Containing a Capsule with an Agent | LIPA, CUTA, FABP4 | SMN1; SMN2 2885/4885CYP3A4 3235/4885HSD11B1 3514/4885 |
| US-20170216165-A1 | Compositions Containing a Capsule with a Moisturizing Agent | CUTA, LIPA, PLIN5 | SMN1; SMN2 3137/4885CYP3A4 3613/4885HSD11B1 3463/4885 |
| US-11491088-B2 | Compositions containing a capsule with a moisturizing agent | CUTA, LIPA, PLIN5 | SMN1; SMN2 3137/4885CYP3A4 3613/4885HSD11B1 3463/4885 |
| US-10322301-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CUTA, ACMSD, TYR | SMN1; SMN2 3220/4885CYP3A4 2323/4885HSD11B1 1697/4885 |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | MSN, LIPE, CUTA | SMN1; SMN2 937/4885CYP3A4 3904/4885HSD11B1 3236/4885 |
| US-11839674-B2 | Compositions comprising silicon dioxide-based particles including one or more agents | MSN, LIPE, CUTA | SMN1; SMN2 936/4885CYP3A4 3902/4885HSD11B1 3215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.